These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 9570364)
21. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma. Li X; Nong Z; Ekström C; Larsson E; Nordlinder H; Hofmann WJ; Trautwein C; Odenthal M; Dienes HP; Ekström TJ; Schirmacher P Cancer Res; 1997 May; 57(10):2048-54. PubMed ID: 9158004 [TBL] [Abstract][Full Text] [Related]
22. Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway. Brown KW; Villar AJ; Bickmore W; Clayton-Smith J; Catchpoole D; Maher ER; Reik W Hum Mol Genet; 1996 Dec; 5(12):2027-32. PubMed ID: 8968759 [TBL] [Abstract][Full Text] [Related]
23. IGF2 but not H19 shows loss of imprinting in human glioma. Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084 [TBL] [Abstract][Full Text] [Related]
24. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting. Dao D; Walsh CP; Yuan L; Gorelov D; Feng L; Hensle T; Nisen P; Yamashiro DJ; Bestor TH; Tycko B Hum Mol Genet; 1999 Jul; 8(7):1337-52. PubMed ID: 10369881 [TBL] [Abstract][Full Text] [Related]
25. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. Ulaner GA; Vu TH; Li T; Hu JF; Yao XM; Yang Y; Gorlick R; Meyers P; Healey J; Ladanyi M; Hoffman AR Hum Mol Genet; 2003 Mar; 12(5):535-49. PubMed ID: 12588801 [TBL] [Abstract][Full Text] [Related]
26. [VIGILIN involves in regulation of imprinting gene IGF2 and H19 in human hepatocellular carcinoma cell]. Ge YJ; Xie XY; Yang B; Chai XJ; Zhang YC; Qin Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):770-4. PubMed ID: 19950580 [TBL] [Abstract][Full Text] [Related]
27. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665 [TBL] [Abstract][Full Text] [Related]
28. Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19. Hu JF; Vu TH; Hoffman AR J Biol Chem; 1997 Aug; 272(33):20715-20. PubMed ID: 9252392 [TBL] [Abstract][Full Text] [Related]
29. Genomic imprinting in the rat: linkage of Igf2 and H19 genes and opposite parental allele-specific expression during embryogenesis. Overall M; Bakker M; Spencer J; Parker N; Smith P; Dziadek M Genomics; 1997 Oct; 45(2):416-20. PubMed ID: 9344669 [TBL] [Abstract][Full Text] [Related]
30. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis. Cui H; Hedborg F; He L; Nordenskjöld A; Sandstedt B; Pfeifer-Ohlsson S; Ohlsson R Cancer Res; 1997 Oct; 57(20):4469-73. PubMed ID: 9377554 [TBL] [Abstract][Full Text] [Related]
31. Genomic imprinting of IGF-II and H19 in adult human pancreatic tissues. Micha AE; Hähnel S; Friess H; Büchler MW; Adler G; Gress TM Digestion; 1999; 60(5):477-83. PubMed ID: 10473973 [TBL] [Abstract][Full Text] [Related]
32. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas. Rainho CA; Kowalski LP; Rogatto SR Head Neck; 2001 Oct; 23(10):851-9. PubMed ID: 11592232 [TBL] [Abstract][Full Text] [Related]
33. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor. Vu TH; Hoffman A J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549 [TBL] [Abstract][Full Text] [Related]
34. Igf2 imprinting does not require its own DNA methylation or H19 RNA. Jones BK; Levorse JM; Tilghman SM Genes Dev; 1998 Jul; 12(14):2200-7. PubMed ID: 9679064 [TBL] [Abstract][Full Text] [Related]
35. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma. el-Naggar AK; Lai S; Tucker SA; Clayman GL; Goepfert H; Hong WK; Huff V Oncogene; 1999 Nov; 18(50):7063-9. PubMed ID: 10597307 [TBL] [Abstract][Full Text] [Related]
36. Role of genomic imprinting in Wilms' tumour and overgrowth disorders. Reeve AE Med Pediatr Oncol; 1996 Nov; 27(5):470-5. PubMed ID: 8827076 [TBL] [Abstract][Full Text] [Related]
37. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Anderson J; Gordon A; McManus A; Shipley J; Pritchard-Jones K Neoplasia; 1999 Oct; 1(4):340-8. PubMed ID: 10935489 [TBL] [Abstract][Full Text] [Related]
38. Alterations of H19 imprinting and IGF2 replication timing are infrequent in Beckwith-Wiedemann syndrome. Squire JA; Li M; Perlikowski S; Fei YL; Bayani J; Zhang ZM; Weksberg R Genomics; 2000 May; 65(3):234-42. PubMed ID: 10857747 [TBL] [Abstract][Full Text] [Related]
39. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321 [TBL] [Abstract][Full Text] [Related]
40. Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma. Casola S; Pedone PV; Cavazzana AO; Basso G; Luksch R; d'Amore ES; Carli M; Bruni CB; Riccio A Oncogene; 1997 Mar; 14(12):1503-10. PubMed ID: 9136994 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]